Creaney, Jenette
Patch, Ann-Marie
Addala, Venkateswar
Sneddon, Sophie A.
Nones, Katia
Dick, Ian M.
Lee, Y. C. Gary
Newell, Felicity
Rouse, Ebony J.
Naeini, Marjan M.
Kondrashova, Olga
Lakis, Vanessa
Nakas, Apostolos
Waller, David
Sharkey, Annabel
Mukhopadhyay, Pamela
Kazakoff, Stephen H.
Koufariotis, Lambros T.
Davidson, Aimee L.
Ramarao-Milne, Priya
Holmes, Oliver
Xu, Qinying
Leonard, Conrad
Wood, Scott
Grimmond, Sean M.
Bueno, Raphael
Fennell, Dean A.
Pearson, John V.
Robinson, Bruce W. https://orcid.org/0000-0001-7865-2760
Waddell, Nicola https://orcid.org/0000-0002-3950-2476
Funding for this research was provided by:
National Health and Medical Research Council (APP1089404, 1139071, APP1108638)
Australian Government Research Training Program (na)
QIMR Berghofer Medical Research Institute (na)
Ian Potter Foundation (na)
The John Thomas Wilson Endowment (na)
Estate of Mr Stewart Coggins (na)
Article History
Received: 18 August 2021
Accepted: 15 May 2022
First Online: 30 May 2022
Declarations
:
: All patients provided written informed consent to participate in this study with approval of the Dana-Farber Brigham and Women’s Cancer Center Institutional Review Board (Boston, MA, USA), University Hospitals of Leicester National Health Service Trust (Leicester, UK) and the Sir Charles Gairdner and Osborne Park Hospital Research Ethics Committee (SCGOPH REC; Perth, Western Australia, Australia). The study was approved by the Sir Charles Gairdner and Osborne Park Hospital Research Ethics Committee (RGS0000001517). The WGS analysis was conducted at QIMR Berghofer with approval from the QIMR Berghofer Research Ethics Committee (P3521). The research in this manuscript conforms to the principles of the Helsinki Declaration.
: All patients provided written informed consent for the study and consented to publishing all patient-related data included in this study.
: JV Pearson and N Waddell are founders of genomiQa Pty Ltd, and members of the genomiQa Board. The remaining authors declare that they have no competing interests.